Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.
about
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activityReassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisDeficient phosphorylation of Stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-betaElevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patientsBlood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-β therapy.Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients
P2860
Q28275948-857A2138-5487-4C81-A843-3BCE653E26B9Q28740839-680F0E3C-01E6-43B8-88D0-44E33DADD4C0Q35106187-B941CF26-C128-4738-93FF-A1BE9849D4EBQ36298955-9CF5332C-B1EA-48B4-BD89-BC6D8EB02B34Q37139127-F5F2EC36-D2E0-4505-ADA9-04BFD00901CDQ37193914-38FA905B-9284-4CB1-94DA-606DE74FA53FQ37367956-2AF1D660-6883-44E3-A0E5-6BE3460DA0C2Q39622523-9720C324-ACD4-4F03-8541-E2F54C95E223Q46435155-85A91AEC-4E68-470D-B914-1DE586DBEB48Q51025796-DDD3533B-38C2-490A-8D97-06165BACAC69Q51089837-ED78ACE1-F549-4BE4-BB7C-3FE7235C8311Q51491050-812D821D-634D-4726-B241-4B2F37C1983DQ57417460-5430926D-E166-41F5-A258-F11F72BF0B13
P2860
Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sieving treatment biomarkers f ...... of multiple sclerosis therapy.
@en
Sieving treatment biomarkers f ...... of multiple sclerosis therapy.
@nl
type
label
Sieving treatment biomarkers f ...... of multiple sclerosis therapy.
@en
Sieving treatment biomarkers f ...... of multiple sclerosis therapy.
@nl
prefLabel
Sieving treatment biomarkers f ...... of multiple sclerosis therapy.
@en
Sieving treatment biomarkers f ...... of multiple sclerosis therapy.
@nl
P2860
P921
P356
P1433
P1476
Sieving treatment biomarkers f ...... of multiple sclerosis therapy
@en
P2093
Robert H Goertsches
Uwe K Zettl
P2860
P304
P356
10.2217/PGS.10.190
P577
2011-03-01T00:00:00Z